fbpx
Study Finds Cannabis Compounds Prevent Infection By Covid-19 Virus

Study Finds Cannabis Compounds Prevent Infection By Covid-19 Virus

cannabis can help with covid-19

Compounds in cannabis can prevent infection from the virus that causes Covid-19 by blocking its entry into cells, according to a study published this week by researchers affiliated with Oregon State University.

A report on the research, “Cannabinoids Block Cellular Entry of SARS-CoV-2 and the Emerging Variants,” was published online on Monday by the Journal of Natural Products.

The researchers found that two cannabinoid acids commonly found in hemp varietals of cannabis, cannabigerolic acid, or CBGA, and cannabidiolic acid, also known as CBDA, can bind to the spike protein of SARS-CoV-2, the virus that causes Covid-19. By binding to the spike protein, the compounds can prevent the virus from entering cells and causing infection, potentially offering new avenues to prevent and treat the disease.

“Orally bioavailable and with a long history of safe human use, these cannabinoids, isolated or in hemp extracts, have the potential to prevent as well as treat infection by SARS-CoV-2,” the researchers wrote in an abstract of the study.

The study was led by Richard van Breemen, a researcher with Oregon State’s Global Hemp Innovation Center in the College of Pharmacy and Linus Pauling Institute, in collaboration with scientists at the Oregon Health & Science University. Van Breeman said that the cannabinoids studied are common and readily available.

“These cannabinoid acids are abundant in hemp and in many hemp extracts,” van Breemen said, as quoted by local media. “They are not controlled substances like THC, the psychoactive ingredient in marijuana, and have a good safety profile in humans.”

Cannabinoids Effective Against New Variants

Van Breemen added that CBDA and CBGA blocked the action of emerging variants of the virus that causes Covid-19, saying that “our research showed the hemp compounds were equally effective against variants of SARS-CoV-2, including variant B.1.1.7, which was first detected in the United Kingdom, and variant B.1.351, first detected in South Africa.”

Cannabis Study Shows Occasional Use Does Not Cause Lung Damage

Cannabis Study Shows Occasional Use Does Not Cause Lung Damage

cannabis study shows cannabis use does not decrease lung function

A study, carried out by the Coronary Artery Risk Development in Young Adults (CARDIA), examined both the short- and long-term effects of cannabis on lung function.

The relationship between cannabis and lung function has been a subject of heated debate for decades. Many are aware of the harm that smoking tobacco causes to the lungs. If anything, the image of what the lungs of a smoker look like is etched in the minds of many. When it comes to smoking cannabis, obvious deductions are often made. Is there any science to back this?

Tobacco smoking has been linked to chronic obstructive pulmonary disease (COPD). [1] It is also the leading cause of preventable death in the U.S. [2,3] While cannabis smoke contains similar combustion products, it is unclear whether cannabis causes an equivalent level of destruction to the lungs.

Some studies have shown that cannabis smoke causes inflammation of the airway mucosa and triggers pulmonary symptoms such as coughing, increased phlegm production, and wheezing. [4-6] However, there are no studies that have demonstrated a decline in pulmonary function. [7]

As the legalization wave continues to sweep through the U.S, increasingly more people are smoking cannabis. Any adverse long-term effects of cannabis on the lungs is a public health issue that requires immediate attention.

A study, carried out by the Coronary Artery Risk Development in Young Adults (CARDIA), sought to understand both the short- and long-term effects of cannabis on lung function. [8] This was compared to data collected from tobacco smokers.

Social Share Buttons and Icons powered by Ultimatelysocial
error

Like The Real Dirt? Please spread the word :)